David R. Wells - 15 Oct 2023 Form 4 Insider Report for Envoy Medical, Inc. (COCH)

Reporting relationship: Chief Financial Officer
Issuer ticker: COCH
Reported as of: 15 Oct 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Oct 2023, 16:09:42 UTC
Prior SEC filing: 29 Sep 2023
Next SEC filing: 21 Jan 2025
Source filing: View source filing
Reporting owner signature: s/ Andrew Nick as Attorney-in-Fact for David R. Wells pursuant to Power of Attorney previously filed

Key filing fact

David R. Wells filed Form 4 for Envoy Medical, Inc. (COCH) on 17 Oct 2023.

Key facts

This page summarizes David R. Wells's Form 4 filing for Envoy Medical, Inc. (COCH).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 17 Oct 2023, 16:09.

Change

Previous filing in this sequence was filed on 29 Sep 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ANZU transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +293,250
Change %
Price: $0.000000
Shares after: 293,250
Date: 15 Oct 2023
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 293,250
Exercise price: $2.40
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Options to purchase 73,313 shares vest on 10/15/2024, and the remaining 219,937 shares vest pro rata on the 15th of each month thereafter for 36 consecutive months.